Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1961 Mar 31;113(4):759–784. doi: 10.1084/jem.113.4.759

THE ANALYSIS OF STREPTOCOCCAL INFECTIONS

V. CARDIOTOXICITY OF STREPTOLYSIN O FOR RABBITS IN VIVO

S P Halbert 1, R Bircher 1, E Dahle 1
PMCID: PMC2137376  PMID: 13710681

Abstract

1. The rapid death which occurred after intravenous injection of activated streptolysin O from. Group A or Group C streptococci was always preceded by profound electrocardiographic alterations. After several multiples of the LD50 doses, cardiac electrical arrest or fibrillation could occur within 2 to 4 seconds after completion of the injection. 2. The streptolysin O preparations used were rather highly purified, but were known to be contaminated with small amounts of one or two other immunologically distinct components. Evidence that the observed results were due to streptolysin O was obtained by tests of the reversibly oxidized materials, and by cholesterol inactivation, as well as by in vivo protection with human gamma globulin rich in antistreptolysin antibodies. 3. Four non-streptolysin streptococcal antigens, partially or highly purified, failed to produce similar electrocardiographic changes, and were much less toxic. One of these was 3 X recrystallized and 1 X rechromatographed streptococcal proteinase. Shigella paradysenteriae type III endotoxin also did not produce striking electrocardiographic abnormalities. 4. A working hypothesis has been developed implicating streptolysin O as the etiological streptococcal factor responsible for the pathogenesis of rheumatic fever, which seems to account for the principal features of this illness.

Full Text

The Full Text of this article is available as a PDF (3.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERNHEIMER A. W., CARLSON A. S., FREEMAN E. B., KELLNER A. Loss of myocardial contractility induced in isolated mammalian hearts by streptolysin O. J Exp Med. 1956 Sep 1;104(3):361–373. doi: 10.1084/jem.104.3.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BERNHEIMER A. W., CARLSON A. S., KELLNER A. Selective inhibition by preparations of streptococcal filtrates of the oxidative metabolism of mitochondria procured from rabbit myocardium. J Exp Med. 1956 Oct 1;104(4):577–587. doi: 10.1084/jem.104.4.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bernheimer A. W., Cantoni G. L. THE CARDIOTOXIC ACTION OF PREPARATIONS CONTAINING THE OXYGEN-LABILE HEMOLYSIN OF STREPTOCOCCUS PYOGENES : I. INCREASED SENSITIVITY OF THE ISOLATED FROG'S HEART TO REPEATED APPLICATION OF THE TOXIN. J Exp Med. 1945 Mar 1;81(3):295–306. doi: 10.1084/jem.81.3.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coburn A. F., Pauli R. H. STUDIES ON THE IMMUNE RESPONSE OF THE RHEUMATIC SUBJECT AND ITS RELATIONSHIP TO ACTIVITY OF THE RHEUMATIC PROCESS. IV. CHARACTERISTICS OF STRAINS OF HEMOLYTIC STREPTOCOCCUS, EFFECTIVE AND NON-EFFECTIVE IN INITIATING RHEUMATIC ACTIVITY. J Clin Invest. 1935 Nov;14(6):755–762. doi: 10.1172/JCI100723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GLASER R. J., THOMAS W. A., MORSE S. I., DARNELL J. E., Jr The incidence and pathogenesis of myocarditis in rabbits after group A streptococcal pharyngeal infections. J Exp Med. 1956 Jan 1;103(1):173–188. doi: 10.1084/jem.103.1.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Goebel W. F., Binkley F., Perlman E. STUDIES ON THE FLEXNER GROUP OF DYSENTERY BACILLI : I. THE SPECIFIC ANTIGENS OF SHIGELLA PARADYSENTERIAE (FLEXNER). J Exp Med. 1945 Apr 1;81(4):315–330. doi: 10.1084/jem.81.4.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HALBERT S. P., AUERBACH T. The use of precipitin analysis in agar for the study of human streptococcal infections. IV. Further observations on the purification of group A extracellular antigens. J Exp Med. 1961 Jan 1;113:131–158. doi: 10.1084/jem.113.1.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HALBERT S. P., BIRCHER R., DAHLE E. Cardiac effects of streptolysin O in rabbits. Nature. 1961 Jan 21;189:232–233. doi: 10.1038/189232a0. [DOI] [PubMed] [Google Scholar]
  9. HALBERT S. P., SWICK L., SONN C. The use of precipitin analysis in agar for the study of human streptococcal infections. I. Oudin technic. J Exp Med. 1955 May 1;101(5):539–556. doi: 10.1084/jem.101.5.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. HALBERT S. P., SWICK L., SONN C. The use of precipitin analysis in agar for the study of human streptococcal infections. II. Ouchterlony and Oakley technics. J Exp Med. 1955 May 1;101(5):557–576. doi: 10.1084/jem.101.5.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. HALBERT S. P. The use of precipitin analysis in agar for the study of human streptococcal infections. III. The purification of some of the antigens detected by these methods. J Exp Med. 1958 Sep 1;108(3):385–410. doi: 10.1084/jem.108.3.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. HARRIS T. N., HARRIS S. Turbidimetric measurement of streptococcal antihyaluronidase in the sera of patients with streptococcal infection and rheumatic fever. J Immunol. 1949 Nov;63(3):249–260. [PubMed] [Google Scholar]
  13. HOUSER H. B., ECKHARDT G. C., HAHN E. O., DENNY F. W., WANNAMAKER L. W., RAMMELKAMP C. H., Jr Effect of aureomycin treatment of streptococcal sore throat, on the streptococcal carrier state, the immunologic response of the host, and the incidence of acute rheumatic fever. Pediatrics. 1953 Dec;12(6):593–606. [PubMed] [Google Scholar]
  14. HOWARD J. G., WALLACE K. R., WRIGHT G. P. The inhibitory effects of cholesterol and related sterols on haemolysis by streptolysin O. Br J Exp Pathol. 1953 Apr;34(2):174–180. [PMC free article] [PubMed] [Google Scholar]
  15. Herbert D., Todd E. W. Purification and properties of a haemolysin produced by group A haemolytic streptococci (streptolysin O). Biochem J. 1941 Nov;35(10-11):1124–1139. doi: 10.1042/bj0351124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. KAPLAN M. H. The concept of autoantibodies in rheumatic fever and in the postcommissurotomy state. Ann N Y Acad Sci. 1960 Jun 30;86:974–991. doi: 10.1111/j.1749-6632.1960.tb42854.x. [DOI] [PubMed] [Google Scholar]
  17. KELLNER A., ROBERTSON T. Myocardial necrosis produced in animals by means of crystalline streptococcal proteinase. J Exp Med. 1954 May 1;99(5):495–503. doi: 10.1084/jem.99.5.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. KIRSCHNER L., HOWIE J. B. Rheumatio-like lesions in the heart of the rabbit experimentally induced by repeated inoculation with haemolytic streptococci. J Pathol Bacteriol. 1952 Apr;64(2):367–377. doi: 10.1002/path.1700640212. [DOI] [PubMed] [Google Scholar]
  19. MASSELL B. F., STURGIS G. P., KNOBLOCH J. D., STREEPER R. B., HALL T. N., NORCROSS P. Prevention of rheumatic fever by prompt penicillin therapy of hemolytic streptococcic respiratory infections; progress report. J Am Med Assoc. 1951 Aug 18;146(16):1469–1474. doi: 10.1001/jama.1951.03670160011004. [DOI] [PubMed] [Google Scholar]
  20. MURPHY G. E., SWIFT H. F. Induction of cardiac lesions, closely resembling those of rheumatic fever, in rabbits following repeated skin infections with group A streptococci. J Exp Med. 1949 Jun 1;89(6):687–698. doi: 10.1084/jem.89.6.687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. OGBURN C. A., HARRIS T. N., HARRIS S. The determination of streptococcal antiproteinase titers in sera of patients with rheumatic fever and streptococcal infection. J Immunol. 1958 Nov;81(5):396–403. [PubMed] [Google Scholar]
  22. OKER-BLOM N., NIKKILA E., KALAJA T. Non-specific antistreptolysin reactions in hepatitis sera; antistreptolysin titers before and after removal of lipids from the hepatitis sera with bentonite. Ann Med Exp Biol Fenn. 1950;28(2):125–134. [PubMed] [Google Scholar]
  23. Packalén T. Nonspecific Antistreptolysin Reactions and Serum (or Pleural-Exudate) Cholesterol. J Bacteriol. 1948 Aug;56(2):143–156. [PMC free article] [PubMed] [Google Scholar]
  24. QUINN R. W., SEASTONE C. V., DICKIE H. A. Antibody production and tuberculin sensitivity in individuals with a history of rheumatic fever. J Immunol. 1953 May;70(5):493–495. [PubMed] [Google Scholar]
  25. QUINN R. W. The antitoxin response of Schick-negative rheumatic and non-rheumatic subjects to diphtheria toxoid. J Immunol. 1956 Mar;76(3):246–252. [PubMed] [Google Scholar]
  26. SCHWAB J. H., WATSON D. W., CROMARTIE W. J. Further studies of group A streptococcal factors with lethal and cardiotoxic properties. J Infect Dis. 1955 Jan-Feb;96(1):14–18. doi: 10.1093/infdis/96.1.14. [DOI] [PubMed] [Google Scholar]
  27. WALTER H., ZIPPER H. Dissociation of some injected antigen-antibody complexes in vivo. Proc Soc Exp Biol Med. 1960 Jan;103:221–223. doi: 10.3181/00379727-103-25465. [DOI] [PubMed] [Google Scholar]
  28. WANNAMAKER L. W., RAMMELKAMP C. H., Jr, DENNY F. W., BRINK W. R., HOUSER H. B., HAHN E. O., DINGLE J. H. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin. Am J Med. 1951 Jun;10(6):673–695. doi: 10.1016/0002-9343(51)90336-1. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES